Morningstar® Stock Report™

Biotest AG BIOd

Gewinnmarge (% des Umsatzes)
20192020202120222023
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten69,27%73,13%84,35%75,80%59,06%
Bruttogewinn30,73%26,87%15,65%24,20%40,94%
Vertriebsgemeinkosten19,30%16,19%15,75%15,64%11,83%
Forschung und Entwicklung12,74%11,52%10,14%9,78%9,76%
Umsatzrendite-1,60%-0,52%-10,10%-1,65%17,54%
Net Int, Inc and Other-1,91%-6,71%-22,25%-7,61%33,07%
EBIT Marge-0,31%-6,20%-12,14%-5,97%15,53%
Ertragskraft
20192020202120222023
Steuersatz0,81%0,29%0,14%0,16%-3,02%
Nettomarge-1,12%-6,48%-12,30%-6,14%18,55%
Gesamtkapitalrendite-0,47-2,84-5,71-2,789,72
Financial Leverage2,322,562,903,242,83
Eigenkapitalsrendite-1,05-6,92-15,52-8,5429,20